Tempus AI, Inc. (NASDAQ:TEM) Shares Acquired by Rakuten Securities Inc.

Rakuten Securities Inc. lifted its position in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 51.6% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 13,194 shares of the company's stock after buying an additional 4,492 shares during the period. Rakuten Securities Inc.'s holdings in Tempus AI were worth $636,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in the company. Wells Fargo & Company MN raised its position in Tempus AI by 13.2% in the fourth quarter. Wells Fargo & Company MN now owns 2,384 shares of the company's stock valued at $80,000 after purchasing an additional 278 shares during the period. Operose Advisors LLC acquired a new stake in shares of Tempus AI during the 4th quarter worth about $25,000. Prestige Wealth Management Group LLC increased its position in shares of Tempus AI by 910.4% during the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company's stock worth $36,000 after purchasing an additional 965 shares during the last quarter. Farther Finance Advisors LLC purchased a new stake in Tempus AI in the 4th quarter valued at about $34,000. Finally, First Horizon Advisors Inc. lifted its position in Tempus AI by 207.9% in the fourth quarter. First Horizon Advisors Inc. now owns 1,641 shares of the company's stock valued at $55,000 after buying an additional 1,108 shares during the last quarter. Hedge funds and other institutional investors own 24.22% of the company's stock.

Insider Transactions at Tempus AI

In other news, Director Wayne A.I. Frederick sold 3,000 shares of the company's stock in a transaction on Monday, March 31st. The shares were sold at an average price of $45.54, for a total value of $136,620.00. Following the completion of the transaction, the director now owns 26,514 shares in the company, valued at approximately $1,207,447.56. This represents a 10.16% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CAO Ryan M. Bartolucci sold 6,073 shares of Tempus AI stock in a transaction on Tuesday, May 20th. The stock was sold at an average price of $63.23, for a total transaction of $383,995.79. Following the sale, the chief accounting officer now owns 47,799 shares in the company, valued at $3,022,330.77. This represents a 11.27% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 308,580 shares of company stock valued at $20,156,721. Corporate insiders own 27.60% of the company's stock.

Tempus AI Stock Down 2.6%

Shares of NASDAQ:TEM traded down $1.89 during trading hours on Tuesday, reaching $70.11. The stock had a trading volume of 7,750,102 shares, compared to its average volume of 7,020,634. Tempus AI, Inc. has a 1 year low of $22.89 and a 1 year high of $91.45. The firm's 50 day moving average is $56.60 and its 200-day moving average is $52.38. The stock has a market capitalization of $12.14 billion and a price-to-earnings ratio of -8.99. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69.

Tempus AI (NASDAQ:TEM - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported ($0.24) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.03. The business had revenue of $255.74 million during the quarter, compared to analysts' expectations of $248.13 million. Tempus AI's revenue was up 75.4% compared to the same quarter last year. Research analysts predict that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on TEM shares. Piper Sandler lifted their price target on shares of Tempus AI from $55.00 to $70.00 and gave the company a "neutral" rating in a research report on Thursday, May 15th. BTIG Research started coverage on Tempus AI in a research report on Monday, April 21st. They issued a "buy" rating and a $60.00 target price on the stock. William Blair restated a "market perform" rating on shares of Tempus AI in a research note on Tuesday, February 25th. Guggenheim reaffirmed a "buy" rating on shares of Tempus AI in a research note on Tuesday, February 25th. Finally, JPMorgan Chase & Co. downgraded Tempus AI from an "overweight" rating to a "neutral" rating and boosted their price objective for the company from $50.00 to $55.00 in a report on Tuesday, February 25th. Six research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Tempus AI currently has an average rating of "Moderate Buy" and a consensus price target of $63.42.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.